This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked PIWIL2 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PIWIL2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~109.8 kDa | |
| Gel | 8–10% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Methylated | |
| Caveat | Antibody identity mismatch | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 2 isoform(s) |
The A04654-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HepG2 cell lysate (catalog A04654-1) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A04654-1 · 1 μg/mL (catalog A04654-1) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
PIWIL2 is predicted at 109.8 kDa; alternative splicing could affect size, but no empirical migration or resolvable isoform pattern is supplied.
| Single band near 109.8 kDa | Consistent with the predicted PIWIL2 mass; confirm identity with controls |
| Several bands at different sizes | Isoforms 1 and 2 could contribute, but distinct migration is unconfirmed |
| Band above 109.8 kDa | Identity and cause of the higher apparent mass require validation |
| Band below 109.8 kDa | An isoform is possible, but its mass and migration are unknown |
| Predicted PIWIL2 mass | Places the full-length reference near 109.8 kDa |
| Alternative splicing | May change protein size, but no isoform masses are supplied |
| Isoform 1 | Its individual apparent band size is unknown |
| Isoform 2 | Its size relative to isoform 1 is unknown |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | PIWIL2 is associated with germ-cell structures, so the sample may have little expression | Check expression in the sample and include a suitable positive control |
| Band higher than expected | No supplied feature establishes an upward shift | Verify identity with PIWIL2 depletion and an independent antibody |
| Band lower than expected | An isoform is possible, but no isoform mass is supplied | Check antibody epitope coverage and confirm the band by PIWIL2 depletion |
| Multiple bands | Isoforms 1 and 2 may contribute; distinct migration is unconfirmed | Compare epitope coverage and test which bands respond to PIWIL2 depletion |
| Weak or no signal | Low PIWIL2 abundance in the sampled cells is possible | Use a suitable positive control and check sample expression |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for PIWIL2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-PIWIL2 antibody, A04654-1, with stated human and mouse reactivity. Its WB caption reports HepG2 cell lysate at 1 μg/mL, but names a PIWI-L1 antibody, so the image’s antibody identity is unclear.
Which to pick: A04654-1 is the only listed option. It has a WB image with a reported HepG2 sample, but confirm the antibody used before relying on that image; the caption names PIWI-L1 despite the PIWI-L2 product name.